Bid Publish Date
13-Dec-2024, 12:05 pm
Bid End Date
04-Jan-2025, 12:00 pm
Location
Progress
Quantity
33530
Category
Cap Tacrolimus 1mg prolonged release
Bid Type
Two Packet Bid
A tender has been published for Indian Army Gliclazide MR 30mg Tab, Glipizide 5mf Tab, Tab Vildagliptin 50mg, Linagliptin 5mg Tab, Cap Tacrolimus 0. 5mg prolonged release, Cap Tacrolimus 1mg prolonged release, Acyclovir Ophth Ointment 3percent ww in 5gm Tube, Ciprofloxacin 0. 3percent eye drops of 3mg ml bott of 5ml, Cyclosporine eye drop 0. 05percent bott of 3ml, Fluconazole 0. 3percent wv bott of 5ml, Flurbiprofen Sodium ophthalmic soln 0. 03percent vial of 5ml, Gatifloxacin 0. 3percent eye drop bott of 5ml in CENTRAL DELHI, DELHI. Quantity: 33530 by. Submission Deadline: 04-01-2025 12: 00: 00. Check eligibility and apply.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Gliclazide MR 30mg Tab , Glipizide 5mf Tab , Tab Vildagliptin 50mg , Linagliptin 5mg Tab , Cap Tacrolimus 0.5mg prolonged release , Cap Tacrolimus 1mg prolonged release , Acyclovir Ophth Ointment 3percent ww in 5gm Tube , Ciprofloxacin 0.3percent eye drops of 3mg ml bott of 5ml , Cyclosporine eye drop 0.05percent bott of 3ml , Fluconazole 0.3percent wv bott of 5ml , Flurbiprofen Sodium ophthalmic soln 0.03percent vial of 5ml , Gatifloxacin 0.3percent eye drop bott of 5ml
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Gliclazide MR 30mg Tab
Gliclazide MR 30mg Tab
Glipizide 5mf Tab
Glipizide 5mf Tab
Tab Vildagliptin 50mg
Tab Vildagliptin 50mg
Linagliptin 5mg Tab
Linagliptin 5mg Tab
Cap Tacrolimus 0.5mg prolonged release
Cap Tacrolimus 0.5mg prolonged release
Cap Tacrolimus 1mg prolonged release
Cap Tacrolimus 1mg prolonged release
Acyclovir Ophth Ointment 3percent ww in 5gm Tube
Acyclovir Ophth Ointment 3% w/w in 5gm Tube
Ciprofloxacin 0.3percent eye drops of 3mg ml bott of 5ml
Ciprofloxacin 0.3% eye drops of 3mg/ml bott of 5ml
Cyclosporine eye drop 0.05percent bott of 3ml
Cyclosporine eye drop 0.05% bott of 3ml
Fluconazole 0.3percent wv bott of 5ml
Fluconazole 0.3%w/v bott of 5ml
Flurbiprofen Sodium ophthalmic soln 0.03percent vial of 5ml
Flurbiprofen Sodium ophthalmic soln 0.03% vial of 5ml
Gatifloxacin 0.3percent eye drop bott of 5ml
Gatifloxacin 0.3% eye drop bott of 5ml
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Gliclazide MR 30mg Tab | Gliclazide MR 30mg Tab | 3,000 | no | [email protected] | 15 | |
| 2 | Glipizide 5mf Tab | Glipizide 5mf Tab | 3,000 | no | [email protected] | 15 | |
| 3 | Tab Vildagliptin 50mg | Tab Vildagliptin 50mg | 6,600 | no | [email protected] | 15 | |
| 4 | Linagliptin 5mg Tab | Linagliptin 5mg Tab | 18,000 | tab | [email protected] | 15 | |
| 5 | Cap Tacrolimus 0.5mg prolonged release | Cap Tacrolimus 0.5mg prolonged release | 600 | no | [email protected] | 15 | |
| 6 | Cap Tacrolimus 1mg prolonged release | Cap Tacrolimus 1mg prolonged release | 600 | no | [email protected] | 15 | |
| 7 | Acyclovir Ophth Ointment 3percent ww in 5gm Tube | Acyclovir Ophth Ointment 3% w/w in 5gm Tube | 120 | tube | [email protected] | 15 | |
| 8 | Ciprofloxacin 0.3percent eye drops of 3mg ml bott of 5ml | Ciprofloxacin 0.3% eye drops of 3mg/ml bott of 5ml | 120 | bott | [email protected] | 15 | |
| 9 | Cyclosporine eye drop 0.05percent bott of 3ml | Cyclosporine eye drop 0.05% bott of 3ml | 150 | bott | [email protected] | 15 | |
| 10 | Fluconazole 0.3percent wv bott of 5ml | Fluconazole 0.3%w/v bott of 5ml | 30 | bott | [email protected] | 15 | |
| 11 | Flurbiprofen Sodium ophthalmic soln 0.03percent vial of 5ml | Flurbiprofen Sodium ophthalmic soln 0.03% vial of 5ml | 1,200 | amp | [email protected] | 15 | |
| 12 | Gatifloxacin 0.3percent eye drop bott of 5ml | Gatifloxacin 0.3% eye drop bott of 5ml | 110 | bott | [email protected] | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
07-Jan-2025, 11:00 am
Opening Date
07-Jan-2025, 11:30 am
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | GAGAN ASSOCIATES Under PMA | - | 03-01-2025 20:33:46 | |
| 2 | LUCKYS PHARMA LAB PRIVATE LIMITED Under PMA | - | 06-01-2025 17:46:38 | |
| 3 | M/S NEW WAVES Under PMA | - | 05-01-2025 20:09:01 | |
| 4 | MEDROUTE PHARMACEUTICALS PRIVATE LIMITED Under PMA | - | 06-01-2025 10:29:32 | |
| 5 | NEW LIFE MEDICOS Under PMA | - | 30-12-2024 15:23:14 | |
| 6 | NUTRAKEM PHARMA Under PMA | - | 16-12-2024 13:45:11 | |
| 7 | REKIN PHARMA PRIVATE LIMITED Under PMA | - | 01-01-2025 21:17:37 | |
| 8 | SHRISHTI PHARMACEUTICAL & SURGICALS Under PMA | - | 03-01-2025 19:53:17 | |
| 9 | SUKUN PHARMA Under PMA | - | 27-12-2024 14:16:50 | |
| 10 | VANDANA MEDICO TRADERS Under PMA | - | 06-01-2025 12:56:07 |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity with at least 3 years of past experience in supplying similar products to a Central/State Government or PSU, along with an average OEM turnover of ₹2 Lakh in the last three years.
Bidders must submit the following certificates: OEM Authorization Certificate, Bidder Turnover Certificates, and any other relevant documents as specified in the tender.
To register, bidders must create an account on the relevant government e-marketplace platform, ensuring to complete all mandatory fields and submissions as required.
The tender documents must be submitted in PDF or other specified formats as referenced in the documentation guidelines.
Bidders must meet the technical specifications and quality standards set by the regulatory authorities, which are detailed in the BoQ documentation.
Yes, all supplied pharmaceuticals must adhere to quality benchmarks established by regulatory bodies relevant to healthcare products.
The tender documentation indicates that no EMD is required for this bid, allowing for easier participation.
While the specifics may vary based on the contract, general guidelines state that performance security may not be required for this tender as indicated in the documents.
Payment terms are typically stipulated in the contract post-award, but bidders should ensure financial viability in their bids that meet government payment timelines.
The evaluation process consists of an item-wise assessment of each bid based on financial aspects, technical compliance, and past performance quantiles.
Bidders will receive a notification of results via the official government procurement platform indicating successful bids and any further instructions.
Yes, the tender grants preferred benefits to Micro, Small, and Medium Enterprises, including exemptions from experience and turnover conditions under specific scenarios.
The 'Make in India' policies provide preferences for local suppliers, promoting domestic sourcing and potentially favoring bids meeting local content requirements.
Bidding timelines for the submission and opening of offers are specified in the tender documentation. Bidders should adhere to these timelines to ensure participation.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS